Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study.
Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study.
复制标题
DOI:
10.1007/s11695-022-06122-9
复制
发表时间:
2022-08
期刊:
影响因子:
2.9
通讯作者:
Acosta, Andres
中科院分区:
文献类型:
--
作者:
Campos, Alejandro;Cifuentes, Lizeth;Hashem, Anas;Busebee, Bradley;Hurtado-Andrade, Maria D.;Ricardo-Silgado, Maria L.;McRae, Alison;de la Rosa, Alan;Feris, Fauzi;Bublitz, Joshua T.;Hensrud, Donald;Camilleri, Michael;Kellogg, Todd A.;Eckel-Passow, Jeanette E.;Olson, Janet;Acosta, Andres
Heterozygous variants in the leptin-melanocortin pathway are associated with obesity. However, their effect on the long-term outcomes after Roux-en-Y gastric bypass (RYGB) is still unknown. In this matched case-control study, 701 participants from the Mayo Clinic Biobank with a history of RYGB were genotyped. Sixty-three patients had a heterozygous variant in the leptin-melanocortin pathway. After excluding patients with potential confounders, carriers were randomly matched (on sex, age, body-mass index [BMI], and years since surgery) with two non-carrier controls. The electronic medical record of carriers and matched non-carriers was reviewed for up to 15 years after RYGB. A total of 50 carriers and 100 matched non-carriers with a history of RYGB were included in the study. Seven different genes (LEPR, PCSK1, POMC, SH2B1, SRC1, MC4R, and SIM1) in the leptin-melanocortin pathway were identified. At the time of surgery, the mean age was 50.8±10.6 years, BMI 45.6±7.3 kg/m2, 79% women. There were no differences in postoperative years of follow-up, Roux limb length, or gastric pouch size between groups. Fifteen years after RYGB, the %TBWL in carriers was −16.6±10.7 compared with −28.7±12.9 in non-carriers (diff=12.1%, 95% CI, 4.8 to 19.3) and weight regain after maximum weight loss was 52.7±29.7% in carriers compared with 29.8±20.7% in non-carriers (diff=22.9%, 95% CI, 5.3 to 40.5). The nadir %TBWL was lower −32.1±8.1% in carriers compared with −36.8±10.4 in non-carriers (diff=4.8%, 95% CI 1.8 to 7.8). Carriers of a heterozygous variant in the leptin-melanocortin pathway have a progressive and significant weight regain in the mid- and long-term after RYGB. Genotyping patients experiencing significant weight regain after RYGB could help implement multidisciplinary and individualized weight-loss interventions to improve weight maintenance after surgery.
登录
查看更多内容
影响因子:
2.9
作者:
Cooiman, M. I.;Kleinendorst, L.;van Haelst, M. M.
通讯作者:
van Haelst, M. M.
影响因子:
5.8
作者:
Hatoum, Ida J.;Stylopoulos, Nicholas;Kaplan, Lee M.
通讯作者:
Kaplan, Lee M.
影响因子:
2.9
作者:
Aslan, Ivy R.;Campos, Guilherme M.;Vaisse, Christian
通讯作者:
Vaisse, Christian
DOI:
10.1001/jama.2018.14433
发表时间:
2018-10-16
期刊:
JAMA
影响因子:
--
作者:
King WC;Hinerman AS;Belle SH;Wahed AS;Courcoulas AP
通讯作者:
Courcoulas AP
影响因子:
2.9
作者:
Li, Yangyang;Zhang, Hong;Hu, Cheng
通讯作者:
Hu, Cheng